| Item Type | Name |
|
Concept
|
Monocytes, Activated Killer
|
|
Concept
|
Monocytes
|
|
Academic Article
|
Effect of recombinant human interleukin 4 on human monocyte activity.
|
|
Academic Article
|
Lithium chloride stimulates human monocytes to secrete tumor necrosis factor/cachectin.
|
|
Academic Article
|
Activation of tumoricidal properties in monocytes from cancer patients following intravenous administration of liposomes containing muramyl tripeptide phosphatidylethanolamine.
|
|
Academic Article
|
Activation or suppression of the tumoricidal properties of monocytes from cancer patients following treatment with human recombinant gamma-interferon.
|
|
Academic Article
|
Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines.
|
|
Academic Article
|
Lymphokine-activated human blood monocytes destroy tumor cells but not normal cells under cocultivation conditions.
|
|
Academic Article
|
Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes.
|
|
Academic Article
|
Altered monocyte chemotactic and activating factor gene expression in human glioblastoma cell lines increased their susceptibility to cytotoxicity.
|
|
Academic Article
|
Muramyl tripeptide phosphatidylethanolamine encapsulated in liposomes stimulates monocyte production of tumor necrosis factor and interleukin-1 in vitro.
|
|
Academic Article
|
Differential release of TNF-alpha, IL 1, and PGE2 by human blood monocytes subsequent to interaction with different bacterial derived agents.
|
|
Academic Article
|
Human monocytes selectively bind to cells expressing the tumorigenic phenotype.
|
|
Academic Article
|
Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.
|
|
Academic Article
|
Intracellular activation of human and rodent macrophages by human lymphokines encapsulated in liposomes.
|
|
Academic Article
|
Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.
|
|
Academic Article
|
Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
|
|
Academic Article
|
Human monocytes activated by immunomodulators in liposomes lyse herpesvirus-infected but not normal cells.
|
|
Academic Article
|
In vitro cellular regulation of monocyte function: evidence for a radiosensitive suppressor.
|
|
Academic Article
|
Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide.
|
|
Academic Article
|
Cytokine production and immune cell activation in melanoma patients treated with liposomal muramyl tripeptide (CGP 19835A lipid).
|
|
Academic Article
|
Liposome-encapsulated muramyl tripeptide up-regulates monocyte chemotactic and activating factor gene expression in human monocytes at the transcriptional and post-transcriptional levels.
|
|
Academic Article
|
ImmTher, a lipophilic disaccharide derivative of muramyl dipeptide, up-regulates specific monocyte cytokine genes and activates monocyte-mediated tumoricidal activity.
|
|
Academic Article
|
Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration.
|
|
Academic Article
|
Influence of chemotherapy administration on monocyte activation by liposomal muramyl tripeptide phosphatidylethanolamine in children with osteosarcoma.
|
|
Academic Article
|
Innate resistance to herpes simplex virus infection. Human lymphocyte and monocyte inhibition of viral replication.
|
|
Academic Article
|
Liposomal MTP-PE for the adjuvant therapy of osteosarcoma.
|
|
Academic Article
|
Activated human blood monocytes trigger the antitumor activity of blood polymorphonuclear cells.
|
|
Academic Article
|
A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1.
|
|
Academic Article
|
Cytotoxic liposomes: membrane interleukin 1 presented in multilamellar vesicles.
|
|
Academic Article
|
Human monocyte-mediated cytotoxicity against herpes simplex virus-infected cells: activation of cytotoxic monocytes by free and liposome-encapsulated lymphokines.
|
|
Academic Article
|
Activation of monocyte-mediated tumoricidal activity in patients with acquired immunodeficiency syndrome.
|
|
Academic Article
|
Human lymphokine preparations which generate tumoricidal properties of human monocytes in vitro may be distinct from gamma interferon.
|
|
Academic Article
|
Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide.
|
|
Academic Article
|
Ultrastructural studies of the interaction between liposome-activated human blood monocytes and allogeneic tumor cells in vitro.
|
|
Academic Article
|
Effect of L-phenylalanine mustard, adriamycin, actinomycin D, and 4'-(9-acridinylamino)methanesulfon-m-anisidide on naturally occurring human spontaneous monocyte-mediated cytotoxicity.
|
|
Academic Article
|
Pharmacology of human spontaneous monocyte-mediated cytotoxicity. I. Enhancement by salicylates and steroids.
|
|
Academic Article
|
Effect of Adriamycin on liposomal muramyl tripeptide's ability to up-regulate monocyte cytokine expression.
|
|
Academic Article
|
Liposome-encapsulated MTP-PE: a novel biologic agent for cancer therapy.
|
|
Academic Article
|
Anti-(tumor necrosis factor) alters the response of human monocytes to liposomal muramyl tripeptide.
|
|
Academic Article
|
Effect of ibuprofen on monocyte activation by liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (CGP 19835A): can ibuprofen reduce fever and chills without compromising immune stimulation?
|
|
Academic Article
|
Liposomal muramyl tripeptide upregulates adhesion molecules on the surface of human monocytes.
|
|
Academic Article
|
Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst.
|
|
Academic Article
|
In vitro and in vivo effect of adriamycin therapy on monocyte activation by liposome-encapsulated immunomodulators.
|
|
Academic Article
|
Contradictory action of interleukin-1: cell growth and tumour cell killing.
|
|
Academic Article
|
Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity.
|
|
Academic Article
|
Production and utilization of human lymphokines containing macrophage-activating factor (MAF) activity.
|
|
Academic Article
|
Defective monocyte killing in patients with malignancies and restoration of function during chemotherapy.
|
|
Academic Article
|
Tumoricidal activity of human monocytes: evidence for cytolytic function distinct from that of NK cells.
|
|
Academic Article
|
Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum(II).
|
|
Academic Article
|
Cis-platinum (II)diamminedichloride (PDD) stimulates spontaneous monocyte-mediated cellular cytotoxicity (SMCC)
|
|
Academic Article
|
Effect of various cancer chemotherapeutic agents on naturally occurring human spontaneous monocyte-mediated cytotoxicity (SMMC)
|
|
Academic Article
|
Activation of human monocyte-mediated cytotoxicity by liposomes containing human lymphokine
|
|
Academic Article
|
Human fibroblast interferon inhibits the development of monocyte-mediated cytotoxicity in vitro
|